App helps manage side effects of kidney cancer combo therapy

NCT ID NCT07028125

Recruiting now Disease control Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study tests whether a digital app that tracks symptoms weekly can help doctors better manage side effects in people with advanced kidney cancer taking cabozantinib and nivolumab. About 83 patients will use the app to report how they feel, and doctors can adjust treatment based on the reports. The goal is to see if this approach reduces unplanned hospital visits or treatment changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cabozantinib and nivolumab
What this could lead to: If successful, this could show that digital monitoring helps doctors adjust treatment more quickly, improving quality of life for kidney cancer patients.
What could go wrong: This is a small, early-phase study (83 people) focused on monitoring, not on curing the cancer. The digital tool may not lead to better outcomes or may be burdensome for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

clear cell renal carcinoma kidney cancer Neoplasm Metastasis renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOCALLY ADVANCED METASTATIC RENAL CELL CARCINOMA RENAL CELL CARCINOMA (KIDNEY CANCER)

Contacts and locations

Locations

CH Boulogne sur Mer
NOT_YET_RECRUITING

Boulogne-sur-Mer, France
CHU
NOT_YET_RECRUITING

Saint-Etienne, France
Centre Antoine Lacassagne
NOT_YET_RECRUITING

Nice, France
Centre François Baclesse
RECRUITING

Caen, France
Centre Hospitalier d'Annecy
NOT_YET_RECRUITING

Annecy, France
Centre Hospitalier de Bayeux
NOT_YET_RECRUITING

Bayeux, France
Centre Hospitalier de Lorient
NOT_YET_RECRUITING

Lorient, France
Centre Hospitalier de Tours
NOT_YET_RECRUITING

Tours, France
Centre Léon Bérard
NOT_YET_RECRUITING

Lyon, France
Centre d'oncologie St Yves
NOT_YET_RECRUITING

Vannes, France
Chu Montpellier
NOT_YET_RECRUITING

Montpellier, France
Chu Poitiers
NOT_YET_RECRUITING

Poitiers, France
GHR Mulhouse Sud Alsace
RECRUITING

Mulhouse, France
Ghpso Creil
NOT_YET_RECRUITING

Creil, France
Hôpital FOCH
NOT_YET_RECRUITING

Suresnes, France
Institut Andrée Dutreix
NOT_YET_RECRUITING

Coudekerque-Branche, France
Institut Sainte Catherine
RECRUITING

Avignon, France
Institut de cancérologie de Bourgogne
NOT_YET_RECRUITING

Dijon, France
Polyclinique du Parc Elsan
NOT_YET_RECRUITING

Caen, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.